Kiora Pharmaceuticals, Inc.
Nasdaq KPRX · Encinitas, CA
Works in Genetic & rare · Ophthalmology
Kiora Pharmaceuticals, Inc. is a clinical trial sponsor based in Encinitas, CA, listed as Nasdaq KPRX. It has 2 active clinical trials with 64 planned participants, in Genetic & rare and Ophthalmology. Since 2021 it has completed 2 trials and stopped 1 early.
Trial track record · since 2021
Financials · Nasdaq KPRX
Fundraising
Pipeline · 2 active trials
| Stage | Trial | Status |
|---|---|---|
Questions about Kiora Pharmaceuticals, Inc
Kiora Pharmaceuticals, Inc is lead sponsor of 2 active clinical trials on ClinicalTrials.gov, with 64 planned participants, in Genetic & rare, Ophthalmology. Since 2021 it has completed 2 trials and stopped 1 early.
Kiora Pharmaceuticals, Inc is based in Encinitas, CA and is listed as Nasdaq KPRX. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Kiora Pharmaceuticals, Inc; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-09-09.
Approve Suite is not affiliated with Kiora Pharmaceuticals, Inc..
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.